BCI
LLY icon

Brinker Capital Investments’s Eli Lilly LLY Stock Holding History

Brinker Capital Investments’s Portfolio LLY Stock Details LLY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.84K Buy
+2
New +$2.03K ﹤0.01% 1931

Other funds holding LLY

Lilly Endowment
Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $173B AUM 20.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Brinker Capital Investments's LLY Position: Q1 2026 in Review

Brinker Capital Investments reduced its Eli Lilly (LLY) stake by 4.1% in Q1 2026, selling an estimated $2.22M and leaving 51,627 shares worth $47.5M. The position accounts for 0.4% of the portfolio, ranked #36.

Brinker Capital Investments first reported a position in LLY in Q4 2015 and has held it in 29 quarters since. The position peaked at $57.8M in Q4 2025. 4,354 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • Brinker Capital Investments held 51,627 shares of Eli Lilly worth $47.5M as of Q1 2026.
  • Brinker Capital Investments sold 2,186 Eli Lilly shares in Q1 2026, an estimated $2.22M.
  • Eli Lilly made up 0.4% of Brinker Capital Investments's portfolio in Q1 2026, its #36 holding.
  • Brinker Capital Investments first reported a position in Eli Lilly in Q4 2015 and has held it in 29 quarters since.
  • Brinker Capital Investments's Eli Lilly position peaked at $57.8M in Q4 2025.
  • 4,354 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on Brinker Capital Investments's 13F filing for Q1 2026, filed 13 May 2026.